Understanding vaccine manufacturing: the role of global partnerships
A webinar to explain some of the manufacturing approaches being used to deliver an effective and affordable COVID-19 vaccine presented by the Vax Hub team at UCL Biochemical Engineering
Understanding vaccine manufacturing: the role of global partnerships
12 Nov 2020, 11:00 – 12:00
In this interactive session, attendees will hear from Vax-Hub researchers on some of the manufacturing challenges for the current vaccine platforms being explored for COVID-19, as well as how Vax-Hub works through partnerships with LMIC manufacturers to co-design vaccine manufacturing technologies suited to local needs.
There will also be an opportunity to hear from Vax-Hub partner, Hilleman Laboratories (an equal joint-venture partnership formed between Merck Sharp & Dohme Corp. (MSD) and the Wellcome Trust) on the role of collaboration and the value of exchanging of ideas and creating meaningful dialogues to strengthen public health systems and immunization programs in developing countries over the long-term.
recently published two VaxHub policy documents in collaboration with UCL-Policy Impact Unit:
Developing new vaccines for pandemics.
Manufacturing new vaccines for pandemics.
UCL uses a third party (Zoom) to administer our webinar/virtual open days and manage your personal information on our behalf. If you are happy for us to process your data solely for this purpose, please continue by entering your details below. You can find our policy statement for prospective students here:
https://www.ucl.ac.uk/legal-services/privacy/ucl-prospective-students-enquirers-and-applicants-privacy-notice
Sourabh Sobti
Vice President of Vaccine Strategy and Implementation a
Hilleman Laboratories
Further information
Ticketing
Pre-booking essential
Cost
Free
Open to
All
Availability
Yes
Organiser
Dr Stephen Morris
UCL Department of Biochemical Engineering
